EU antitrust regulators set to okay $16.5 bln Novo Holdings, Catalent deal, source says

Reuters

Nov 23, 2024

EU antitrust regulators set to okay $16.5 bln Novo Holdings, <a href="https://laohu8.com/S/CTLT">Catalent</a> deal, source says

BRUSSELS/LONDON, Nov 22 (Reuters) - EU antitrust regulators are set to clear without conditions Novo Holdings' planned $16.5 billion takeover of Catalent CTLT.N, a person with direct knowledge of the matter said on Friday.

Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk NOVOb.CO, whose profits from blockbuster weight-loss drug Wegovy has made it Europe's most valuable company by market value.

(Reporting by Foo Yun Chee in Brussels and Maggie Fick in London; Editing by Louise Heavens)

((foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2485967291"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2485967291\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2485967291?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-23 01:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2485967291","market":"us","top_or_hot":-1,"title":"EU antitrust regulators set to okay $16.5 bln Novo Holdings, Catalent deal, source says","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>EU antitrust regulators set to okay $16.5 bln Novo Holdings, <a href=\"https://laohu8.com/S/CTLT\">Catalent</a> deal, source says</title></head><body><p><span>BRUSSELS/LONDON, Nov 22 (Reuters)</span><span> - </span>EU antitrust regulators are set to clear without conditions Novo Holdings' planned $16.5 billion takeover of Catalent <span>CTLT.N</span>, a person with direct knowledge of the matter said on Friday.</p><p>Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk <span>NOVOb.CO</span>, whose profits from blockbuster weight-loss drug Wegovy has made it Europe's most valuable company by market value.</p><p> (Reporting by Foo Yun Chee in Brussels and Maggie Fick in London; Editing by Louise Heavens)</p><p> ((foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU antitrust regulators set to okay $16.5 bln Novo Holdings, Catalent deal, source says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU antitrust regulators set to okay $16.5 bln Novo Holdings, Catalent deal, source says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-11-23 01:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>EU antitrust regulators set to okay $16.5 bln Novo Holdings, <a href=\"https://laohu8.com/S/CTLT\">Catalent</a> deal, source says</title></head><body><p><span>BRUSSELS/LONDON, Nov 22 (Reuters)</span><span> - </span>EU antitrust regulators are set to clear without conditions Novo Holdings' planned $16.5 billion takeover of Catalent <span>CTLT.N</span>, a person with direct knowledge of the matter said on Friday.</p><p>Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk <span>NOVOb.CO</span>, whose profits from blockbuster weight-loss drug Wegovy has made it Europe's most valuable company by market value.</p><p> (Reporting by Foo Yun Chee in Brussels and Maggie Fick in London; Editing by Louise Heavens)</p><p> ((foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4530","symbol_name":"医药外包概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL8N3MT1QU:1","article_id":"2485967291","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2485967291","pubTimestamp":1732296496,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"EU antitrust regulators set to okay $16.5 bln Novo Holdings, Catalent deal, source saysBRUSSELS/LONDON, Nov 22 (Reuters) - EU antitrust regulators are set to clear without conditions Novo Holdings' pl","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4530":"医药外包概念","BK4588":"碎股","BK4007":"制药","CTLT":"Catalent","BK4585":"ETF&股票定投概念"},"translate_title":"消息人士称，欧盟反垄断监管机构将批准Novo Holdings与Catalent价值165亿美元的交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTLT":0.9},"content_text":"EU antitrust regulators set to okay $16.5 bln Novo Holdings, Catalent deal, source saysBRUSSELS/LONDON, Nov 22 (Reuters) - EU antitrust regulators are set to clear without conditions Novo Holdings' planned $16.5 billion takeover of Catalent CTLT.N, a person with direct knowledge of the matter said on Friday.Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk NOVOb.CO, whose profits from blockbuster weight-loss drug Wegovy has made it Europe's most valuable company by market value. (Reporting by Foo Yun Chee in Brussels and Maggie Fick in London; Editing by Louise Heavens) ((foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}